Is there an association between regulatory actions for indoor tanning (banning all commercial indoor tanning and prohibiting use by minors only) and health and economic outcomes?
In this economic analysis of persons aged 12 to 35 years, despite decreasing indoor tanning rates across North America and Europe, banning indoor tanning for the next generation of individuals aged 12 to 35 years could avert 448 000 melanomas and 9.7 million keratinocyte carcinomas and generate health care cost savings of US $5.7 billion, whereas prohibiting only minors from indoor tanning could produce one-third of these benefits.
Banning all commercial indoor tanning may be associated with substantially greater health and economic benefit than prohibiting use by minors only.
UV radiation emissions from indoor tanning devices are carcinogenic. Regulatory actions may be associated with reduced exposure of UV radiation at a population level.
To estimate the long-term health and economic consequences of banning indoor tanning devices or prohibiting their use by minors only in North America and Europe compared with ongoing current levels of use.
Design, Setting, and Participants
This economic analysis modeled data for individuals 12 to 35 years old in North America and Europe, who commonly engage in indoor tanning. A Markov cohort model was used with outcomes projected during the cohort’s remaining life-years. Models were populated by extracting data from high-quality systematic reviews and meta-analyses, epidemiologic reports, and cancer registrations.
Main Outcomes and Measures
Main outcomes were numbers of melanomas and deaths from melanoma, numbers of keratinocyte carcinomas, life-years, and health care and productivity costs. Extensive sensitivity analyses were performed to assess the stability of results.
In an estimated population of 110 932 523 in the United States and Canada and 141 970 492 in Europe, for the next generation of youths and young adults during their remaining lifespans, regulatory actions that ban indoor tanning devices could be expected to gain 423 000 life-years, avert 240 000 melanomas (−8.2%), and avert 7.3 million keratinocyte carcinomas (−7.8%) in North America and gain 460 000 life-years, avert 204 000 melanomas (−4.9%), and avert 2.4 million keratinocyte carcinomas (−4.4%) in Europe compared with ongoing current levels of use. Economic cost savings of US $31.1 billion in North America and €21.1 billion (US $15.9 billion) in Europe could occur. Skin cancers averted and cost savings after prohibiting indoor tanning by minors may be associated with one-third of the corresponding benefits of a total ban.
Conclusions and Relevance
Banning indoor tanning may be associated with reduced skin cancer burden and health care costs. Corresponding gains from prohibiting indoor tanning by minors only may be smaller.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Gordon LG, Rodriguez-Acevedo AJ, Køster B, et al. Association of Indoor Tanning Regulations With Health and Economic Outcomes in North America and Europe. JAMA Dermatol. 2020;156(4):401–410. doi:10.1001/jamadermatol.2020.0001
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: